Abstract
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
M L Ogletree, D N Harris, W A Schumacher, M L Webb and R N Misra
Journal of Pharmacology and Experimental Therapeutics February 1993, 264 (2) 570-578;